459 related articles for article (PubMed ID: 29437725)
21. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states.
Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T
Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437
[TBL] [Abstract][Full Text] [Related]
22. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression.
Dalvai M; Bellucci L; Fleury L; Lavigne AC; Moutahir F; Bystricky K
Oncogene; 2013 Sep; 32(36):4243-51. PubMed ID: 23108396
[TBL] [Abstract][Full Text] [Related]
23. Insulin-dependent transcriptional control in L6 rat myotubes is associated with modulation of histone acetylation and accumulation of the histone variant H2A.Z in the proximity of the transcriptional start site.
Zerzaihi O; Chriett S; Vidal H; Pirola L
Biochem Cell Biol; 2014 Feb; 92(1):61-7. PubMed ID: 24471919
[TBL] [Abstract][Full Text] [Related]
24. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
Gallant-Behm CL; Espinosa JM
Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
[TBL] [Abstract][Full Text] [Related]
25. Association of Taf14 with acetylated histone H3 directs gene transcription and the DNA damage response.
Shanle EK; Andrews FH; Meriesh H; McDaniel SL; Dronamraju R; DiFiore JV; Jha D; Wozniak GG; Bridgers JB; Kerschner JL; Krajewski K; Martín GM; Morrison AJ; Kutateladze TG; Strahl BD
Genes Dev; 2015 Sep; 29(17):1795-800. PubMed ID: 26341557
[TBL] [Abstract][Full Text] [Related]
26. NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters.
Gatta R; Mantovani R
Epigenetics; 2011 Apr; 6(4):526-34. PubMed ID: 21304275
[TBL] [Abstract][Full Text] [Related]
27. The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.
Wai DCC; Szyszka TN; Campbell AE; Kwong C; Wilkinson-White LE; Silva APG; Low JKK; Kwan AH; Gamsjaeger R; Chalmers JD; Patrick WM; Lu B; Vakoc CR; Blobel GA; Mackay JP
J Biol Chem; 2018 May; 293(19):7160-7175. PubMed ID: 29567837
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Christott T; Bennett J; Coxon C; Monteiro O; Giroud C; Beke V; Felce SL; Gamble V; Gileadi C; Poda G; Al-Awar R; Farnie G; Fedorov O
SLAS Discov; 2019 Feb; 24(2):133-141. PubMed ID: 30359161
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal protein interaction domain of the chromatin reader Yaf9 is critical for pathogenesis of
Lo TL; Wang Q; Nickson J; van Denderen BJW; Deveson Lucas D; Chai HX; Knott GJ; Weerasinghe H; Traven A
mSphere; 2024 Mar; 9(3):e0069623. PubMed ID: 38376217
[TBL] [Abstract][Full Text] [Related]
30. Structural Insights into Histone Crotonyl-Lysine Recognition by the AF9 YEATS Domain.
Zhang Q; Zeng L; Zhao C; Ju Y; Konuma T; Zhou MM
Structure; 2016 Sep; 24(9):1606-12. PubMed ID: 27545619
[TBL] [Abstract][Full Text] [Related]
31. Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation.
Jiang Y; Chen G; Li XM; Liu S; Tian G; Li Y; Li X; Li H; Li XD
J Am Chem Soc; 2020 Dec; 142(51):21450-21459. PubMed ID: 33306911
[TBL] [Abstract][Full Text] [Related]
32. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes.
Li N; Li Y; Lv J; Zheng X; Wen H; Shen H; Zhu G; Chen TY; Dhar SS; Kan PY; Wang Z; Shiekhattar R; Shi X; Lan F; Chen K; Li W; Li H; Lee MG
Mol Cell; 2016 Aug; 63(3):470-84. PubMed ID: 27477906
[TBL] [Abstract][Full Text] [Related]
33. Histone variant H2A.Z marks the 5' ends of both active and inactive genes in euchromatin.
Raisner RM; Hartley PD; Meneghini MD; Bao MZ; Liu CL; Schreiber SL; Rando OJ; Madhani HD
Cell; 2005 Oct; 123(2):233-48. PubMed ID: 16239142
[TBL] [Abstract][Full Text] [Related]
34. Oxoglutarate dehydrogenase and acetyl-CoA acyltransferase 2 selectively associate with H2A.Z-occupied promoters and are required for histone modifications.
Choi S; Pfleger J; Jeon YH; Yang Z; He M; Shin H; Sayed D; Astrof S; Abdellatif M
Biochim Biophys Acta Gene Regul Mech; 2019 Oct; 1862(10):194436. PubMed ID: 31682939
[TBL] [Abstract][Full Text] [Related]
35. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.
Kabra A; Bushweller J
J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
[TBL] [Abstract][Full Text] [Related]
36. JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory Regions.
Procida T; Friedrich T; Jack APM; Peritore M; Bönisch C; Eberl HC; Daus N; Kletenkov K; Nist A; Stiewe T; Borggrefe T; Mann M; Bartkuhn M; Hake SB
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445503
[TBL] [Abstract][Full Text] [Related]
37. Unveiling the role of GAS41 in cancer progression.
Ji K; Li L; Liu H; Shen Y; Jiang J; Zhang M; Teng H; Yan X; Zhang Y; Cai Y; Zhou H
Cancer Cell Int; 2023 Oct; 23(1):245. PubMed ID: 37853482
[TBL] [Abstract][Full Text] [Related]
38. Global histone modifications predict prognosis of resected non small-cell lung cancer.
Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
[TBL] [Abstract][Full Text] [Related]
39. Multifaceted roles of YEATS domain-containing proteins and novel links to neurological diseases.
Yeewa R; Chaiya P; Jantrapirom S; Shotelersuk V; Lo Piccolo L
Cell Mol Life Sci; 2022 Mar; 79(3):183. PubMed ID: 35279775
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Myc-induced histone modifications on target chromatin.
Martinato F; Cesaroni M; Amati B; Guccione E
PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
